<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for VPHM</title>
    <link />
    <description>Headlines for ViroPharma, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Viropharma's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435621-viropharma-s-ceo-presents-at-bank-of-america-merrill-lynch-health-care-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 00:22:07 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma (VPHM) Shares Cross Above 200 DMA</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11921613/1/viropharma-vphm-shares-cross-above-200-dma.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 13 May 2013 12:17:00 GMT</pubDate>
    </item>
    <item>
      <title>Despite Poor Quarter, ViroPharma's Commercial And Pipeline Progress Continue</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1402151-despite-poor-quarter-viropharma-s-commercial-and-pipeline-progress-continue.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 21:10:53 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma Reports Loss in 1Q - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98490/viropharma-reports-loss-in-1q.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 02 May 2013 13:09:01 GMT</pubDate>
    </item>
    <item>
      <title>Optimer's Dificid Cleared Down Under - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98394/optimers-dificid-cleared-down-under.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 01 May 2013 17:28:01 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma Goes Negative</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/viropharma-goes-negative/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 17:06:47 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1390551-viropharma-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 15:20:10 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma's Maribavir: Rising Like Phoenix</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1389661-viropharma-s-maribavir-rising-like-phoenix.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 13:02:02 GMT</pubDate>
    </item>
    <item>
      <title>Pipeline Progresses at ViroPharma - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97732/pipeline-progresses-at-viropharma.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 23 Apr 2013 17:50:01 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma Says Phase 2 Study of VP20621 Resulted In High Rates Of Colonization, Statistically Signi</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3515116/viropharma-says-phase-2-study-of-vp20621-resulted-in-high-rates-of-colonization-s.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 22 Apr 2013 07:47:29 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Lightning Round - Travelers Will Travel To $100 (4/17/13)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1350101-cramer-s-lightning-round-travelers-will-travel-to-100-4-17-13.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 06:54:21 GMT</pubDate>
    </item>
    <item>
      <title>Bullish Two Hundred Day Moving Average Cross - VPHM</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11894816/1/bullish-two-hundred-day-moving-average-cross--vphm.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 12 Apr 2013 17:17:00 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma: Generic Concerns Overblown, Pipeline Will Bring Revenue Diversity</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1317551-viropharma-generic-concerns-overblown-pipeline-will-bring-revenue-diversity.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 03 Apr 2013 10:27:32 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: J.P. Morgan Upgrades Viropharma to Overweight on Higher Cinryze Conviction</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3450686/update-j-p-morgan-upgrades-viropharma-to-overweight-on-h.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 27 Mar 2013 08:59:39 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Upgrades</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/upgrades/13/03/3450223/benzingas-top-upgrades.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 27 Mar 2013 07:23:10 GMT</pubDate>
    </item>
    <item>
      <title>Whoa! These Stocks Outpaced the Dow</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/25/whoa-these-stocks-outpaced-the-dow/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 25 Mar 2013 13:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Shire Buys Premacure  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94823/shire-buys-premacure.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 14 Mar 2013 17:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Top Stock Picks: WPRT VPHM TXN JDSU CSC</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11864692/1/cramers-top-stock-picks-wprt-vphm-txn-jdsu-csc.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Sat, 09 Mar 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma Tops on All Fronts - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93736/viropharma-tops-on-all-fronts.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 28 Feb 2013 16:38:01 GMT</pubDate>
    </item>
    <item>
      <title>ViroPharma Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1230701-viropharma-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Feb 2013 15:40:23 GMT</pubDate>
    </item>
  </channel>
</rss>
